ClinicalTrials.gg
Status unknownNCT05644886FPFPUpdated Dec 13, 2022

Pilot Study on Engaging Family Physicians in Family Planning in Pakistan

An interventional study of FP Training and Technical Support in Contraceptive Usage and Contraception, sponsored by Population Council. Status unknown at 1 site in Pakistan. Open to male participants aged 22 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-13.

Sponsored by Population Council · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
22 Years to 70 Years
Sex
Male
01

Study summary

This study aims to generate evidence on the feasibility and effectiveness of engaging for-profit private sector family physicians and pharmacies to include family planning (FP) as a routine service in rural areas of Pakistan. The study will enlist family physicians and pharmacies in rural areas of Islamabad, Pakistan. Physicians will be randomly assigned to intervention and control groups. Those in intervention arm will received training on family planning and technical support for six months during the duration of the study, to evaluate the impact of training and support in expanding family planning coverage and impact.

Read the detailed description

Pakistan has an overall national goal under the National Plan of Action on Population Growth and the national commitment for the international FP2030 goals to expand family planning services by raising Contraceptive Prevalence Rate (CPR) to 60 percent by 2030 in Pakistan . Based on the Population Council's earlier Landscape study of Family planning services, the total market approach has not been fully adopted in Pakistan (The Population Council, 2016). It called for the inclusion of the private sector and pharmacies to expand access to family planning services and commodities. Another study by the Council also explored the potential of including the private sector and proposed the case for engaging family physicians in family planning . The National Plan of Action on Population Growth's recommendation no. 2 calls for engaging the for-profit private sector, especially family physicians in efforts to expand family planning services . However, a review of evidence in 2020 noted that no determined effort was found to engage private physicians to provide family planning in a sustainable and for-profit model. Internationally, the involvement of the private sector in family planning has been proposed as a High Impact Practice (HIP). The ultimate goal of this study is to provide a model for a successful engagement of male family physicians and pharmacies in family planning and, thereby, expanding family planning services in rural areas to achieve universal access to FP. The engagement of for-profit (male) family physicians in the provision of FP services in linkage with pharmacies will combine three high-impact practices (HIPs) in family planning: (i) private sector engagement (ii) male participation in family planning (Khan, K \& Sathar, Z, 2020) and (iii) integrating pharmacies in the health system.

This study aims to generate evidence on the feasibility and effectiveness of engaging for-profit private sector family physicians and pharmacies to include family planning (FP) as a routine service. It aims to fill the knowledge gap about the effectiveness of engaging private sector family physicians, and also the optimal approach of integrating family physicians' and pharmacies in Pakistan. Given that the lack of family planning services is particularly dire in rural areas, we situate the study in the rural areas of Islamabad. The study outcomes would provide evidence for advocacy for a sustainable model that can be scaled up to both rural and urban areas.

The study involves an intervention to test the feasibility of engaging male family physicians and pharmacies in expanding the provision of family planning services in the rural areas, on the basis of a review of previous studies, and discussions with a number of private providers, pharmacists, government officials and researchers, The impact of the intervention is to be tested through a randomized control study. The study will enlist family physicians and pharmacies in rural Islamabad Capital Territory (ICT) , who will give their written and informed consent to participate in the study. Physicians will be randomly assigned to intervention and control groups with equal chances of falling into each group.

  • The intervention will provide male family physicians with training and technical support and integrates them with the nearest pharmacies or drug shops for vertical referrals. Technical support will include:
  • Supportive supervision
  • Peer-to-peer support
  • Strengthening referrals for long-acting reversible contraceptives (LARC) and permanent methods
  • Provision of information, education, and communication (IEC) material and LCD for display of visual material.
  • Branding of clinics with signboards
  • Provision of family planning prescription booklets The providers in the intervention group will receive the intervention package, the providers in the control group will continue to provide their services as usual with no exposure to intervention activities. After the end of the intervention period, providers that fall into control areas will be provided the same training. We hypothesize that the proposed intervention will enable male family physicians to provide information, counselling, family planning prescriptions, and referrals, as requested by clients and will result in increased uptake of contraceptive methods.

To evaluate intervention outcomes, baseline assessments in both intervention and control arms will obtain quantitative data from family physicians and pharmacies. We will assess our primary and secondary outcomes using the Management Information System (MIS) tool for obtaining routine service statistics data from clinics and contraceptive sales data from pharmacies. After 6 months of completing the intervention, end-line assessments will be conducted with family physicians in both intervention and control arms to measure changes in providers' KAP towards FP due to intervention. We will also interview family physicians in the intervention arm to get their feedback on the intervention's effectiveness and feasibility through in-depth interviews.

In addition, data on contraceptive availability and sales trends, monitoring stock positions, will be obtained from pharmacies, those nearest to; and linked with participating clinics, at the start, at 3 months, and at 6 months of intervention. The regular availability of contraceptives at the participating pharmacies will be ensured, and mechanisms to address declining stocks or stock outs would be addressed by linking with manufacturers and distributors and with health or population welfare department facilities if needed.

02

Conditions studied

  • Contraceptive Usage
  • Contraception

Keywords

  • Family Planning
  • Pakistan
  • Family Physicians
  • Contraceptive
  • Pharmacies
  • Male
03

In context

Contraception Behavior

132 studies on the registry are indexed under Contraception Behavior; 20 are open to participants now.

This study's planned enrollment of 76 is below the median of 382 across 106 interventional studies indexed under Contraception Behavior.

Browse Contraception Behavior studies →

Lead sponsor

Population Council is the lead sponsor of 26 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 70 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Private clinics with a male family physician
  • Male family physician working on a regular basis (3 or more days a week)
  • Clinics located in Islamabad rural areas.

Exclusion criteria

Exclusion Criteria:

  • Clinics or facilities with specialized care (skin care, laser clinics, surgical clinics, among others)
  • Clinics located in ICT urban areas
  • Male family physicians working in a private clinic where a female medical doctor attends to patients during the same working hours.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Intervention Arm

    Male Family Physicians allocated to intervention arm will receive following: Training and technical support and integrates them with the nearest pharmacies or drug shops for vertical referrals. Technical support will include: * Supportive supervision * Peer-to-peer support * Strengthening referrals for long-acting reversible contraceptives (LARC) and permanent methods * Provision of information, education, and communication (IEC) material and LCD for display of visual material. * Branding of clinics with name boards * Provision of family planning prescription booklets

    Behavioral: FP Training and Technical Support

  • No intervention
    Control Arm

    the providers in the control group will continue to provide their services as usual with no exposure to intervention activities. After the end of the intervention period, providers that fall into control areas will be provided the same training.

Interventions

  • BehavioralFP Training and Technical Support

    Same as in Intervention arm description

06

What researchers measure

Primary outcomes

  1. Proportion of family physicians successfully providing family planning services to their clients

    the proportion of family physicians in the intervention arm compared to the control arm providing FP services to at least 10 per cent of their total clients during the intervention period.

    Time frame: 6-months

Secondary outcomes

  1. change in contraceptive uptake

    2. Percentage point difference in contraceptive sales in pharmacies linked to clinics in the intervention arm as compared to the control arm.

    Time frame: 6-months

  2. change in number of FP clients

    Estimate the average (mean) number of clients receiving FP services in the intervention group compared to the control group by the end of intervention period.

    Time frame: 6-months

07

Study locations

1 of 1 sites recruiting
  • Population Council
    Islamabad, Islamabad Capital Territory 44050, Pakistan
    Recruiting
08

References and documents

Publications

  • Federal and Provincial Task Force s, 2019, Action Plan (2019-24) for Implementation of Recommendations Approved by CCI Regarding Alarming Population Growth in Pakistan.
  • The Population Council. 2016. Landscape Analysis of Family Planning Situation in Pakistan: Brief Summary of Findings. Islamabad: The Population Council
  • Rehman Ashfaq and Malkani Anam. 2020. Best Bets for Accelerating Family Planning in Pakistan: The Case for Engaging Family Physicians and the for-Profit Private Sector. Islamabad: Population Research Center and the Population Council.
  • Khan, K., & Sathar, Z. (2020). Best Bets for Accelerating Family Planning in Pakistan: Inducting men, sharing responsibility
  • The Population Council. 2019. Improving Access to Family Planning Services through the Private Sector in Pakistan: A Stakeholder Analysis. Islamabad: The Population Council.
  • Bradley, S.E & Shiras, T. Pharmacies and Drug Shops. Expanding contraceptive Choice and access in the private sector. Family Planning High Impact Practices2021

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05644886
Lead sponsor
Population Council
Collaborators
Bill and Melinda Gates Foundation
Responsible party
Ayaz Ahmed Baloch (Program Manager Research, Population Council) — Principal investigator
First posted
Dec 9, 2022
Start date
Nov 21, 2022
Primary completion
Jun 30, 2023 (estimated)
Completion
Aug 30, 2023 (estimated)
Last update
Dec 13, 2022

Study contacts

Manager Research
Contact
abaloch@popcouncil.org
+92(051)9205566 ext. 136
Ayaz Ahmed Baloch
principal investigator · Population Council

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion